APOA4 Antikörper
(1 reference)-
- Target Alle APOA4 Antikörper anzeigen
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOA4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of APOA4.
- Sequenz
- C-KEKESQDKTL SLP
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human APOA4.
- Top Product
- Discover our top product APOA4 Primärantikörper
-
anti-Apolipoprotein A-IV (APOA4) (AA 135-281) antibody
APOA4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 299-369) antibodyAPOA4 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 173-396) antibodyAPOA4 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-120) antibodyAPOA4 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-391) antibodyAPOA4 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 1-396) antibodyAPOA4 Reaktivität: Human WB, IHC (p) Wirt: Maus Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (Internal Region) antibodyVerified APOA4 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) antibodyAPOA4 Reaktivität: Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 21-382) antibodyAPOA4 Reaktivität: Schwein WB, IHC, IP, ICC Wirt: Maus Monoclonal A8 unconjugated
anti-Apolipoprotein A-IV (APOA4) (AA 49-79), (N-Term) antibodyAPOA4 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15153 unconjugated
-
- Applikationshinweise
-
ELISA (1:32000)
Western Blot (0.01-0.03 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance." in: American journal of physiology. Cell physiology, Vol. 290, Issue 1, pp. C95-C103, (2005) (PubMed).
-
: "Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance." in: American journal of physiology. Cell physiology, Vol. 290, Issue 1, pp. C95-C103, (2005) (PubMed).
-
- Target
- APOA4 (Apolipoprotein A-IV (APOA4))
- Andere Bezeichnung
- Apolipoprotein A IV (ApoA IV) (APOA4 Produkte)
- Synonyme
- Apo-AIV antikoerper, ApoA-IV antikoerper, apoAIV antikoerper, APOAIV antikoerper, APOA4 antikoerper, myh11 antikoerper, Apoa-4 antikoerper, apolipoprotein A4 antikoerper, apolipoprotein A4 L homeolog antikoerper, apolipoprotein A-IV antikoerper, apolipoprotein A-IV a antikoerper, APOA4 antikoerper, Apoa4 antikoerper, apoa4 antikoerper, apoa4.L antikoerper, apoa4a antikoerper
- Gen-ID
- 337
- Pathways
- Lipid Metabolism
-
